Man Group PLC Ionis Pharmaceuticals Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 596,263 shares of IONS stock, worth $22.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

596,263

Previous 633,409 5.86%

Holding current value

$22.7 Million

Previous $30.2 Million 20.88%

% of portfolio

0.07%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.49 Million - $1.93 Million	-37,146 Reduced 5.86%	596,263 $23.9 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $13.9 Million - $18.1 Million	380,188 Added 150.14%	633,409 $30.2 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $7.34 Million - $9.36 Million	174,746 Added 222.68%	253,221 $11 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $3.71 Million - $4.41 Million	-85,472 Reduced 52.13%	78,475 $3.97 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $6.31 Million - $7.73 Million	163,947 New	163,947 $7.44 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $664,078 - $814,771	19,776 Added 8.58%	250,301 $8.95 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $1.96 Million - $2.46 Million	52,928 Added 29.8%	230,525 $8.71 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $6.05 Million - $8.06 Million	165,667 Added 1388.66%	177,597 $7.86 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $378,300 - $512,990	11,930 New	11,930 $442,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $281,041 - $373,915	-6,204 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $5.21 Million - $6.91 Million	-109,808 Reduced 94.65%	6,204 $294,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $4.98 Million - $6.49 Million	106,312 Added 1096.0%	116,012 $6.84 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $2.04 Million - $3.1 Million	-48,970 Reduced 83.47%	9,700 $459,000
Q4 2019 Feb 18, 2020	BUY	$53.85 - $65.27 $238,124 - $288,623	4,422 Added 8.15%	58,670 $3.54 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $1.7 Million - $2.07 Million	-28,707 Reduced 34.61%	54,248 $3.25 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $3.85 Million - $5.34 Million	62,031 Added 296.46%	82,955 $5.33 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $836,136 - $1.28 Million	15,800 Added 308.35%	20,924 $1.7 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $301,551 - $413,981	-6,953 Reduced 57.57%	5,124 $277,000
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $258,652 - $323,918	-6,032 Reduced 33.31%	12,077 $623,000
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $547,519 - $684,906	13,509 Added 293.67%	18,109 $755,000
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $202,768 - $253,230	4,600 New	4,600 $203,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account